NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Tuberculosis Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Tuberculosis Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



New findings from Virginia Polytechnic Institute in the area of tuberculosis published



June 15th, 2009

"In mycobacteria, F-420, a deazaflavin derivative, acts as a hydride transfer coenzyme for an F-420-specific glucose-6-phosphate dehydrogenase (Fgd). Physiologically relevant reactions in the mycobacteria that use Fgd-generated reduced F-420 (F420H2) are unknown," researchers in the United States report.

"In this work, F420H2 was found to be oxidized by NO only in the presence of oxygen. Further analysis demonstrated that NO2, produced from NO and O-2, was the oxidant. UV-visible spectroscopic and NO-sensor-based analyses proved that F420H2 reduced NO2 to NO. This reaction could serve as a defense system for Mycobacterium tuberculosis, which is more sensitive to NO2...


Source: Tuberculosis Week (2009-06-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login